End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.8 CNY | +0.20% | -1.14% | -37.05% |
Apr. 26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.05% | 3.27B | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-13.40% | 32.81B | |
+52.41% | 25B | |
-17.27% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024